Structure-function relationships in estrogen receptors and the characterization of novel selective estrogen receptor modulators with unique pharmacological profiles

Annals of the New York Academy of Sciences

Volumn 949, Issue , 2001, Pages 6-15

  Katzenellenbogen, Benita S ^a,b   Sun, Jun ^a   Harrington, William R ^a   Kraichely, Dennis M ^a   Ganessunker, Deshanie ^a   Katzenellenbogen, John A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Coactivators; ER ; ER ; SERMs

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIGAND; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; CONFERENCE PAPER; DRUG RECEPTOR BINDING; HORMONE SUBSTITUTION; HUMAN; LIGAND BINDING; MENOPAUSE; NONHUMAN; OSTEOPOROSIS; PROTEIN DOMAIN; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0035680322     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03998.x     Document Type: Conference Paper

References (38)

1. Selective estrogen receptor modulators (SERMs)
2. The molecular pharmacology of SERMs
3. An issue of tissues: Divining the split personalities of selective estrogen receptor modulators
4. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
5. Estrogen receptors: Selective ligands, partners, and distinctive pharmacology
6. Estrogen receptor alpha and estrogen receptor beta: Regulation by selective estrogen receptor modulators (SERMs) and importance in breast cancer
7. Dissection of the LXXLL nuclear receptor/coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors alpha and beta
8. Peptide antagonists of the human estrogen receptor
9. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta
10. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen
11. Transcription activation by estrogen and progesterone receptors
12. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor
13. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
14. Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras
15. The quinone reductase gene: A unique estrogen receptor-regulated gene that is activated by antiestrogens
16. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
17. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
18. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-α and estrogen receptor-β
19. 2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity
20. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo
21. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation
22. The carboxyl-terminal F domain of the human estrogen receptor: Role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists
23. Identification of cysteine-530 as the covalent attachment site of an affinity labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptor
24. Hormone binding and transcription activation by estrogen receptors: Analyses using mammalian and yeast systems
25. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination
26. An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity
27. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor: Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands
28. Identification of two cysteines closely positioned in the ligand binding pocket of the human estrogen receptor: Roles in ligand binding and transcriptional activation
29. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast
30. Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding
31. Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens
32. Acyclic amides as estrogen receptor ligands: Synthesis, binding, activity, and receptor interaction
33. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β
34. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: Correlations with biological character and distinct differences among SRC coactivator family members
35. Estrogen receptor subtype-selective ligands: Asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetrahydrochrysenes
36. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation
37. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: Correlations with DNA and coregulator interactions and receptor conformational changes
38. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens